Advertisement

Pharmacy

Home Pharmacy
Nocebo hyperalgesia is stronger when an inert treatment is labeled as being an expensive medication rather than a cheap one

Stronger Nocebo Effect When Inert Rx Labeled As Expensive

Neural interactions between cortex, brainstem, and spinal cord mediate this effect
Antiepileptic drug use may increase the risk for pneumonia in patients with Alzheimer disease

AEDs Tied to Higher Pneumonia Risk in Alzheimer Patients

Risk for pneumonia highest within first month of antiepileptic drug use but persists through two years
In 2015

Serious Suffering Affects Almost Half of Those Who Die Yearly

Vast majority who experience serious health-related suffering have no palliative care, pain relief
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 29 to July 3

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
For women with urinary tract infections

Sulfonamides, Nitrofurantoin Being Given for UTI in Pregnancy

Nitrofurantoin, trimethoprim-sulfamethoxazole prescribed first trimester despite ACOG recs
Engaging in abusive supervisory behavior may be associated with short-term beneficial effects

Short-Lived Benefits for Abusive Supervisory Behavior

Positive indirect effect on work engagement via recovery level, which is short-lived
Canagliflozin is associated with a reduced risk for renal and cardiovascular events for patients with type 2 diabetes and kidney disease

Canagliflozin Seems Effective for Patients With T2DM, Kidney Disease

Reductions seen in risk for kidney failure, cardiovascular disease with canagliflozin versus placebo
Liraglutide treatment for weight management is not associated with increased risk of cardiovascular events

Liraglutide Not Tied to Higher Risk of Cardiovascular Events

Findings based on post hoc analysis of phase 2 and 3 clinical trials
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 22 to 26

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
A case of remission of psoriasis after treatment of chronic hepatitis C virus has been described in a research letter published online Jan. 16 in the Annals of Internal Medicine.

Psoriasis Remission Described After Hepatitis C Virus Treatment

Case report: After initiation of ledipasvir-sofosbuvir, HCV RNA decreased, and skin lesions improved